Government responds to Lords inquiry on pet parasite medicines and water pollution

The House of Lords Environment and Climate Change Committee examined the environmental impact of pet parasite medicines, such as spot-on flea and tick treatments, in its report "Paws for concern: pets, parasites and pollution", published in August 2026. The inquiry looked at growing evidence that ingredients including fipronil and imidacloprid are turning up in rivers and affecting aquatic wildlife, and made eight recommendations on how their use and sale might be managed more carefully. The Government published its formal response on 5 October 2026.

Ministers agreed, in full or in principle, to most of the Committee's recommendations: publishing anonymised sales and usage data, strengthening the evidence base on environmental contamination, working towards proper environmental risk assessments for these products, and reviewing how the regulator and industry are governed. They stopped short, however, of committing to restrict some treatments to sale through a vet, pharmacist or other qualified adviser, saying a Veterinary Medicines Directorate review of that question is still under way. A call to extend the advised post-treatment bathing restriction from four days to 28 days was rejected outright as "not an appropriate or proportionate regulatory response at this time"; the Government says it will instead continue promoting its existing "Be Spot On Aware" guidance.

For dog and cat owners and breeders, the response doesn't change what's on the shelf or what a vet might prescribe for now, and flea and tick treatments remain a normal, important part of preventative care when used as directed. The debate is really about how these products are sold and used, not whether pets should be protected from parasites, and the sensible takeaway is to keep following label and veterinary advice on dosing and timing rather than treating on a fixed routine regardless of need. Further decisions, including on restricting sales channels, are expected to follow once the Veterinary Medicines Directorate completes its review.